The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $256,004, and 4 are calls, amounting to ...

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

The global pharmaceutical company Teva announced a strategic partnership with Kerry Pharma, a subsidiary of the Kerry Logistics Network Ltd on March 11, further bolstering the pharmaceutical supply ...

Capsaicin cream's only manufacturer has gone bust - leaving sufferers unable to access the medicine, which is used to treat ...

All pharmaceutical manufacturers, including Novo Nordisk (NYSE:NVO) and Teva Pharmaceuticals, have agreed to participate in ...

All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. Mr. Shah Coherent Market Insights Pvt. Ltd. +1 2524771362 email us ...

The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...

Viranchi Shah, national president at Indian Drugs Manufacturers Association (IDMA) said that while India accounts for just 5.6% of the US’ total pharma imports of $160 billion annually ...

A drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time. The words drug, medication and medicine are often used interchangeably.

They do not apply to natural health products, veterinary drugs or over-the-counter drugs. Since March 2017, manufacturers have been mandated to report actual and anticipated drug shortages and ...